Search clinical trials for: Dapagliflozin 10 MG [Farxiga]
Total 1581 results
-
AstraZenecaCompletedChronic Heart Failure With Reduced Ejection Fraction (HFrEF)United States, Canada, Denmark, United Kingdom, Czechia, Vietnam, Germany, Brazil, India, China, Japan, Taiwan, Netherlands, Bulgaria, Slovakia, Hungary, Poland, Russian Federation, Argentina, Sweden
-
Assistance Publique - Hôpitaux de ParisAstraZenecaRecruitingSTEMI | Left Ventricular Dysfunction | NSTEMI | AMIFrance
-
Woman'sAstraZenecaCompletedDapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women (DAPA-GDM)Diabetes Prevention in Women After GDM Who Are at High-riskUnited States
-
University Hospital TuebingenAstraZeneca; German Federal Ministry of Education and Research; German Center...Not yet recruitingRenal Failure | PreDiabetes | Type2diabetesGermany
-
University Hospital TuebingenTerminatedType 2 DiabetesGermany
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
National Taiwan University HospitalRecruitingVentilator Lung | Heart Failure AcuteTaiwan
-
Centro Universitario de Ciencias de la Salud, MexicoUnknownType 2 Diabetes MellitusMexico
-
University of EdinburghAstraZeneca; NHS LothianRecruiting
-
University of LeicesterAstraZeneca; Royal Surrey County Hospital NHS Foundation TrustCompletedThe Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes (SINGLED)Type 2 DiabetesUnited Kingdom
-
AstraZenecaCompletedBioequivalence | Fixed Dose Combination Tablets | Healthy Male and Female SubjectsUnited States
-
Research Clinical Centre of the Russian Railways...UnknownDiabetes Mellitus | Hypoglycemic EpisodesRussian Federation
-
Centro de Diabetes Curitiba LtdaAstraZenecaCompleted
-
AstraZenecaTerminatedType 2 Diabetes MellitusThailand, Vietnam
-
The Hospital for Sick ChildrenJuvenile Diabetes Research Foundation; Canadian Institutes of Health Research...Active, not recruitingAdolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial (ATTEMPT)Diabetes Mellitus, Type 1Canada, United States
-
AstraZenecaParexelCompletedType 2 Diabetes MellitusUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedDiabetes Mellitus, Type 2United States
-
Janssen-Cilag International NVCompleted
-
AstraZenecaCompleted
-
Boehringer IngelheimCompleted
-
Samsung Medical CenterRecruitingTricuspid RegurgitationKorea, Republic of
-
AstraZenecaCompletedHealthy Subjects in Fasted and Fed StateBrazil
-
Collegium Medicum w BydgoszczyRecruitingMetabolic SyndromePoland
-
University of PisaUnknownType 2 Diabetes | Urinary Tract InfectionsItaly
-
University of Mississippi Medical CenterEli Lilly and CompanyRecruiting
-
Maastricht UniversityAstraZenecaCompletedPrediabetic State | Substrate OxidationNetherlands
-
EMSWithdrawnType2 Diabetes Mellitus
-
Butler HospitalNational Institute of Mental Health (NIMH)CompletedSubstance-Related Disorders | Depression | HIV InfectionsUnited States
-
The University of Hong KongNot yet recruitingChronic Kidney Diseases | Lupus NephritisHong Kong
-
Rehab WeridaUniversity of AlexandriaRecruitingType 2 Diabetes | Nonalcoholic Fatty Liver DiseaseEgypt
-
LG ChemUnknown
-
Yale UniversityBoehringer IngelheimRecruitingEnd Stage Renal Disease on DialysisUnited States
-
Spanish Society of CardiologyFundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIActive, not recruitingAortic Stenosis | Transcatether Aortic Valve ImplantationSpain
-
The University of Hong KongCompletedType 2 Diabetes | KetonemiaHong Kong
-
University Health Network, TorontoRecruitingType 2 Diabetes | Kidney Transplant Recipients | Post-transplant Diabetes MellitusCanada
-
Tor Biering-SørensenRecruitingChronic Kidney DiseasesDenmark
-
University of PisaCompletedType2 Diabetes MellitusItaly
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
AstraZenecaParexel; George Clinical Pty LtdTerminatedChronic Kidney DiseaseUnited States, Taiwan, Germany, Hungary, Malaysia, Japan, Israel, Poland, Brazil, Ukraine, Argentina
-
Nanjing First Hospital, Nanjing Medical UniversityUnknownType 2 Diabetes Mellitus
-
University Health Network, TorontoSunnybrook Health Sciences Centre; MOUNT SINAI HOSPITALRecruitingCardiovascular Risk FactorCanada
-
Uppsala UniversityUppsala University Hospital; Swedish Healthcare Regions; Swedish National Board... and other collaboratorsActive, not recruitingType 2 DiabetesSweden
-
Saint Luke's Health SystemCompletedChronic Heart Failure With Preserved Systolic FunctionUnited States
-
The University of Texas Health Science Center at...CompletedType II; DiabetesUnited States
-
University Hospital TuebingenWithdrawn
-
Saint Luke's Health SystemCompletedChronic Heart Failure With Reduced Systolic FunctionUnited States
-
Anemia Working Group RomaniaCarol Davila University of Medicine and Pharmacy; Sf Ioan Emergency Clinical... and other collaboratorsRecruitingChronic Kidney Diseases | Type 2 Diabetes MellitusRomania
-
The University of Hong KongResearch Grant CouncilRecruitingCirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 InhibitorsHong Kong
-
The University of Hong KongFood and Health Bureau, Hong KongCompletedNon-alcoholic Fatty Liver DiseaseHong Kong